High-Risk Multiple Myeloma (MM)
Introduction: Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of malignant plasma cells in the bone
Read moreIntroduction: Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of malignant plasma cells in the bone
Read moreIn October 2023, the 16th European Nursing of Oncology Society’s Conference (EONS16), ‘Cancer nursing: Building on innovation and building back
Read morePancreatic Cancer: A Tough Nut to Crack! Pancreatic cancer presents a significant clinical challenge. Currently, the 5-year survival rate for
Read moreIntroduction to Homologous Recombination Deficiency Homologous recombination deficiency (HRD) represents a pivotal concept in oncology, characterized by a functional loss
Read moreCurrently there are over 200,000 people living with and beyond cancer in Ireland and that number is expected to double
Read moreProf Seamus O’Reilly BSc MD PhD FRCPI is Consultant Medical Oncologist at Cork-Mercy and South Infirmary Victoria University Hospitals, Clinical
Read moreNovember was global lung cancer awareness month. As part of its annual awareness campaign, the Irish Cancer Society (the Society)
Read moreBRCA stands for BReast CAncer gene. BRCA1 and BRCA2 are tumour suppressor genes which means that they stop the cells
Read morePenile cancer is a rare male genital cancer which presents in older men in the 6th or 7th decades. However,
Read moreWritten by Dr Rachel Clarke, Oncology SPR, Dr Mark Doherty, Consultant Oncologist, St Vincent’s University Hospital Immune checkpoint inhibitors have
Read more